It is an efficient app to assess stroke and bleeding risk and the benefits and risks of antithrombotic therapy in patients with chronic atrial fibrillation.
A powerful app for considering the benefits and risks of antithrombotic therapy
It provides support on decision making, and also guide you to consider different therapeutic options.
Tips for using the product
It does not only provide CHADS2-VASC scores, but also information from landmark study like ARISTOTLE. It thus helps you quantify the risk reduction, as well as the bleeding risks with various types of therapies